New Therapies for Functional Bowel Diseases

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2000 Sep 22

PMID 10998662

Authors

B Coulie

M Camilleri

Affiliations

Soon will be listed here.

Abstract

During recent years, a greater understanding of the pathophysiology of functional bowel disease, and a surge of interest in this challenge among pharmacologists, basic scientists, and clinical investigators, have led to novel insights and promising therapies. The evidence to support current therapies in nonculcer dyspepsia and irritable bowel syndrome (IBS) is reviewed, and some of the novel therapeutic approaches on the threshold of clinical application are described.

References

Hislop I . Psychological significance of the irritable colon syndrome. Gut. 1971; 12(6):452-7. PMC: 1411675. DOI: 10.1136/gut.12.6.452. View

Fisher R, Parkman H . Management of nonulcer dyspepsia. N Engl J Med. 1998; 339(19):1376-81. DOI: 10.1056/NEJM199811053391907. View

Dapoigny M, Abitbol J, Fraitag B . Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci. 1995; 40(10):2244-9. DOI: 10.1007/BF02209014. View

Jian R, Ducrot F, Ruskone A, Chaussade S, Rambaud J, Modigliani R . Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci. 1989; 34(5):657-64. DOI: 10.1007/BF01540334. View

Musial F, Enck P, Kalveram K, Erckenbrecht J . The effect of loperamide on anorectal function in normal healthy men. J Clin Gastroenterol. 1992; 15(4):321-4. DOI: 10.1097/00004836-199212000-00011. View

Read M, Read N, Barber D, Duthie H . Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci. 1982; 27(9):807-14. DOI: 10.1007/BF01391374. View

Gorelick A, Koshy S, Hooper F, Bennett T, Chey W, Hasler W . Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol. 1998; 275(3):G460-6. DOI: 10.1152/ajpgi.1998.275.3.G460. View

. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 1998; 114(3):579-81. DOI: 10.1016/s0016-5085(98)70541-4. View

Talley N, Vakil N, Ballard 2nd E, Fennerty M . Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999; 341(15):1106-11. DOI: 10.1056/NEJM199910073411502. View

10.

Barbara L, Camilleri M, Corinaldesi R, CREAN G, Heading R, Johnson A . Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci. 1989; 34(8):1272-6. DOI: 10.1007/BF01537277. View

11.

Ghoos Y, Maes B, Geypens B, Mys G, Hiele M, Rutgeerts P . Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993; 104(6):1640-7. DOI: 10.1016/0016-5085(93)90640-x. View

12.

Thumshirn M, Camilleri M, Saslow S, Williams D, Burton D, Hanson R . Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut. 1998; 44(1):55-64. PMC: 1760076. DOI: 10.1136/gut.44.1.55. View

13.

McColl K, Murray L, El-Omar E, Dickson A, Wirz A, Kelman A . Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998; 339(26):1869-74. DOI: 10.1056/NEJM199812243392601. View

14.

Poynard T, Naveau S, Mory B, Chaput J . Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1994; 8(5):499-510. DOI: 10.1111/j.1365-2036.1994.tb00322.x. View

15.

Talley N, Phillips S, Melton L, Mulvihill C, Wiltgen C, Zinsmeister A . Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990; 31(1):77-81. PMC: 1378344. DOI: 10.1136/gut.31.1.77. View

16.

Heefner J, WILDER R, Wilson I . Irritable colon and depression. Psychosomatics. 1978; 19(9):540-7. DOI: 10.1016/S0033-3182(78)70930-8. View

17.

PROUT B, Pinto T, ANDERSON J, Schiff A . Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand. 1982; 66(1):33-41. DOI: 10.1111/j.1600-0447.1982.tb00912.x. View

18.

Camilleri M, Northcutt A, Kong S, Dukes G, McSorley D, Mangel A . Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000; 355(9209):1035-40. DOI: 10.1016/S0140-6736(00)02033-X. View

19.

Choi M, Camilleri M, Burton D, Zinsmeister A, Forstrom L, Nair K . [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997; 112(4):1155-62. DOI: 10.1016/s0016-5085(97)70126-4. View

20.

Thumshirn M, Camilleri M, Choi M, Zinsmeister A . Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology. 1999; 116(3):573-85. DOI: 10.1016/s0016-5085(99)70179-4. View